Streamlined Risk Assessment. Personalized Care.

Breast screening is rapidly moving into an era of personalized care guided by risk assessment. Having efficient tools to estimate a patient’s risk of developing cancer helps the care team determine prevention and early detection pathways.

VolparaRisk in Practice

Integrates with Volpara®Scorecard+™ to give radiologists access to risk insights while reading studies

Breast Density in Risk Assessment

Breast density is an independent risk factor for the development of breast cancer and has been demonstrated to add accuracy to the TC8 risk calculation.1,2 Volpara's volumetric breast density (VBD%) is the only automated density assessment validated with the TC8 risk model.

VolparaDensity is FDA cleared to provide both volumetric breast density measurements and a breast density category, shown to correlate to BI-RADS® 4th and 5th Edition density categories, from most digital mammography vendors.